Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)

Abstract Background Primary intestinal lymphangiectasia or Waldmann’s disease (ORPHA code: 90362) is a very rare disorder of unknown etiology, characterized by digestive lymphatic vessel dilations. Main body of the abstract The objective of the French National Diagnosis and Care Protocol (PNDS; Prot...

Full description

Saved in:
Bibliographic Details
Main Authors: Stéphane Vignes, Mathieu Uzzan, Lionel Arrivé, Françoise Le Pimpec-Barthes, Claire Fieschi, Guillaume Lefèvre, Manon Javalet, Joanna Bettolo, Béatrice Dubern
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-025-03657-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849761267689979904
author Stéphane Vignes
Mathieu Uzzan
Lionel Arrivé
Françoise Le Pimpec-Barthes
Claire Fieschi
Guillaume Lefèvre
Manon Javalet
Joanna Bettolo
Béatrice Dubern
author_facet Stéphane Vignes
Mathieu Uzzan
Lionel Arrivé
Françoise Le Pimpec-Barthes
Claire Fieschi
Guillaume Lefèvre
Manon Javalet
Joanna Bettolo
Béatrice Dubern
author_sort Stéphane Vignes
collection DOAJ
description Abstract Background Primary intestinal lymphangiectasia or Waldmann’s disease (ORPHA code: 90362) is a very rare disorder of unknown etiology, characterized by digestive lymphatic vessel dilations. Main body of the abstract The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) is to provide health professionals with information about the optimal management and care for patients, based on a critical literature review and multidisciplinary expert consensus. The PNDS, written by members of the French National Reference Centers for Rare Vascular diseases and Rare Digestive diseases, is available from the French Health Authority website. The latter allow lymph leakage (chyle) into the intestinal lumen that is responsible for protein-losing gastroenteropathy, combining hypoalbuminemia, lymphopenia and hypogammaglobulinemia. Diagnosis is usually made before the age of 3, but primary intestinal lymphangiectasia may be discovered in adults. Edema of the lower limbs is the main clinical sign and serous effusions (pleura, peritoneum, pericardium) are sometimes abundant. Exudative gastroenteropathy is confirmed by increased α1-antitrypsin clearance. Esophagogastroduodenoscopy finds milky lesions corresponding to lymphangiectasias; duodenal biopsies confirm the diagnosis. Endoscopic videocapsule may be useful to evaluate the extent of the disease and/or if esophagogastroduodenoscopy is not contributory. In rare cases, the disease may be complicated by digestive or extra-digestive B-cell lymphoma in adults. Management is mainly based on a strict fat-free diet, combined with supplementation with medium-chain triglycerides, essential fatty acids and fat-soluble vitamins. Octreotide, a somatostatin analogue, has inconsistent efficacy, in combination with the fat-free diet and the sometimes-prescribed mammalian target of rapamycin-receptor inhibitor sirolimus, occasionally achieving positive effects. Diuretics and albumin infusions may be useful in addition to the fat-free diet. Intestinal resections are proposed for rare, localized, segmental forms of the disease. Short conclusion Primary intestinal lymphangiectasia is a chronic disease requiring a prolonged restrictive and constraining strict low-fat diet supplemented with medium-chain triglycerides and fat-soluble vitamins. Its evolution can be complicated by more-or-less severe serous effusions and rare lymphoma. Life-long clinical and biological monitoring is required.
format Article
id doaj-art-a5a421af2a0b43dc8aad0503dcd070f4
institution DOAJ
issn 1750-1172
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj-art-a5a421af2a0b43dc8aad0503dcd070f42025-08-20T03:06:05ZengBMCOrphanet Journal of Rare Diseases1750-11722025-07-0120111610.1186/s13023-025-03657-9Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)Stéphane Vignes0Mathieu Uzzan1Lionel Arrivé2Françoise Le Pimpec-Barthes3Claire Fieschi4Guillaume Lefèvre5Manon Javalet6Joanna Bettolo7Béatrice Dubern8Department of Lymphology, Referral Center for Primary Lymphedema, Cognacq-Jay HospitalDepartment of Gastroenterology, Henri-Mondor HospitalDepartment of Radiology, Hôpital Saint-AntoineDepartment of Thoracic Surgery, HEGPDepartment of Immuno-Hematology, Saint-Louis HospitalInstitut of Immunology, CHU de LilleDepartment of Pediatric Gastroenterology and Nutrition, Armand-Trousseau HospitalDepartment of Gastroenterology, Henri-Mondor HospitalDepartment of Pediatric Gastroenterology and Nutrition, Armand-Trousseau HospitalAbstract Background Primary intestinal lymphangiectasia or Waldmann’s disease (ORPHA code: 90362) is a very rare disorder of unknown etiology, characterized by digestive lymphatic vessel dilations. Main body of the abstract The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) is to provide health professionals with information about the optimal management and care for patients, based on a critical literature review and multidisciplinary expert consensus. The PNDS, written by members of the French National Reference Centers for Rare Vascular diseases and Rare Digestive diseases, is available from the French Health Authority website. The latter allow lymph leakage (chyle) into the intestinal lumen that is responsible for protein-losing gastroenteropathy, combining hypoalbuminemia, lymphopenia and hypogammaglobulinemia. Diagnosis is usually made before the age of 3, but primary intestinal lymphangiectasia may be discovered in adults. Edema of the lower limbs is the main clinical sign and serous effusions (pleura, peritoneum, pericardium) are sometimes abundant. Exudative gastroenteropathy is confirmed by increased α1-antitrypsin clearance. Esophagogastroduodenoscopy finds milky lesions corresponding to lymphangiectasias; duodenal biopsies confirm the diagnosis. Endoscopic videocapsule may be useful to evaluate the extent of the disease and/or if esophagogastroduodenoscopy is not contributory. In rare cases, the disease may be complicated by digestive or extra-digestive B-cell lymphoma in adults. Management is mainly based on a strict fat-free diet, combined with supplementation with medium-chain triglycerides, essential fatty acids and fat-soluble vitamins. Octreotide, a somatostatin analogue, has inconsistent efficacy, in combination with the fat-free diet and the sometimes-prescribed mammalian target of rapamycin-receptor inhibitor sirolimus, occasionally achieving positive effects. Diuretics and albumin infusions may be useful in addition to the fat-free diet. Intestinal resections are proposed for rare, localized, segmental forms of the disease. Short conclusion Primary intestinal lymphangiectasia is a chronic disease requiring a prolonged restrictive and constraining strict low-fat diet supplemented with medium-chain triglycerides and fat-soluble vitamins. Its evolution can be complicated by more-or-less severe serous effusions and rare lymphoma. Life-long clinical and biological monitoring is required.https://doi.org/10.1186/s13023-025-03657-9Primary intestinal lymphangiectasiaWaldmann’s diseaseDiagnosisExplorationsComplicationsTreatment
spellingShingle Stéphane Vignes
Mathieu Uzzan
Lionel Arrivé
Françoise Le Pimpec-Barthes
Claire Fieschi
Guillaume Lefèvre
Manon Javalet
Joanna Bettolo
Béatrice Dubern
Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
Orphanet Journal of Rare Diseases
Primary intestinal lymphangiectasia
Waldmann’s disease
Diagnosis
Explorations
Complications
Treatment
title Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
title_full Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
title_fullStr Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
title_full_unstemmed Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
title_short Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
title_sort primary intestinal lymphangiectasia french national diagnosis and care protocol pnds protocole national de diagnostic et de soins
topic Primary intestinal lymphangiectasia
Waldmann’s disease
Diagnosis
Explorations
Complications
Treatment
url https://doi.org/10.1186/s13023-025-03657-9
work_keys_str_mv AT stephanevignes primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT mathieuuzzan primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT lionelarrive primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT francoiselepimpecbarthes primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT clairefieschi primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT guillaumelefevre primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT manonjavalet primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT joannabettolo primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins
AT beatricedubern primaryintestinallymphangiectasiafrenchnationaldiagnosisandcareprotocolpndsprotocolenationaldediagnosticetdesoins